CORC

在结果中检索

CORC

浏览/检索结果: 共128条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Core-shell structure in situ reinforced aluminum matrix composites: Microstructure, mechanical and tribological properties 期刊论文
Journal of Alloys and Compounds, 2022, 卷号: 901, 期号: 0, 页码: 163613
作者:  Ma JQ(马吉强);  Fan CL(樊成龙);  Chen WY(陈文元);  Tan H(谈辉);  Zhu SY(朱圣宇)
收藏  |  浏览/下载：7/0  |  提交时间：2022/12/13
铝锭连续铸造生产线打渣机器人的打渣装置 专利
申请日期: 2019-02-01, 公开日期: 2019-02-01
作者:  罗德春;  冯瑞成;  芮执元;  郭俊锋;  沈浩
收藏  |  浏览/下载：3/0  |  提交时间：2020/11/11
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
ACE inhibitor suppresses cardiac remodeling after myocardial infarction by regulating dendritic cells and AT(2) receptor-mediated mechanism in mice 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 114
作者:  Yuan, Jie;  Ma, Yuanji;  Hu, Jialu;  Gao, Wei;  Zou, Yunzeng
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Analysis of Compounds Dissolved in Nonpolar Solvents by Electrospray Ionization on Conductive Nanomaterials 期刊论文
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2018, 卷号: 29, 期号: 3, 页码: 573-580
作者:  Xia, Bing;  Gao, Yuanji;  Ji, Baocheng;  Ma, Fengwei;  Ding, Lisheng
收藏  |  浏览/下载：17/0  |  提交时间：2020/12/24

©版权所有 ©2017 CSpace - Powered by CSpace